Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Amicus Therapeutics (FOLD) Other Gross PP&E Adjustments (2016 - 2025)

Amicus Therapeutics' Other Gross PP&E Adjustments history spans 14 years, with the latest figure at $37.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 5.33% year-over-year to $37.8 million, compared with a TTM value of $37.8 million through Dec 2025, up 5.33%, and an annual FY2025 reading of $37.8 million, up 5.33% over the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $37.8 million at Amicus Therapeutics, up from -$21.5 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $41.8 million in Q4 2021, with the low at -$32.0 million in Q3 2023.
  • Average Other Gross PP&E Adjustments over 5 years is -$10.6 million, with a median of -$22.3 million recorded in 2021.
  • Year-over-year, Other Gross PP&E Adjustments skyrocketed 31.19% in 2021 and then plummeted 43.71% in 2022.
  • Tracing FOLD's Other Gross PP&E Adjustments over 5 years: stood at $41.8 million in 2021, then tumbled by 43.71% to $23.5 million in 2022, then surged by 30.86% to $30.8 million in 2023, then grew by 16.55% to $35.9 million in 2024, then rose by 5.33% to $37.8 million in 2025.
  • Per Business Quant, the three most recent readings for FOLD's Other Gross PP&E Adjustments are $37.8 million (Q4 2025), -$21.5 million (Q3 2025), and -$22.0 million (Q2 2025).